Baicalein improves behavioral dysfunction induced by Alzheimer's disease in rats

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Alzheimer's disease (AD) is a neurodegenerative disorder linked to increased oxidative stress.
• Medicinal plants with antioxidant properties offer potential therapeutic avenues for diseases like AD.
• Baicalein, a compound from medicinal plants, was investigated for its effects on AD.

Purpose of the Study:

• To explore the protective and therapeutic potential of baicalein in a rat model of Alzheimer's disease.
• To evaluate baicalein's impact on cognitive deficits and biochemical markers associated with AD.
• To compare baicalein's efficacy with rivastigmine, a standard AD treatment.

Main Methods:

• Swiss Wistar rats were induced with Alzheimer's disease using AlCl3.
• Animals were treated with varying doses of baicalein or rivastigmine, both preventively and therapeutically.
• Cognitive functions were assessed using behavioral tests (rotarod, T-maze, cage activity).
• Brain tissue was analyzed for acetylcholinesterase (AchE) and acetylcholine (Ach) levels and histopathological changes.

Main Results:

• Baicalein demonstrated a dose-dependent improvement in cognitive functions, including rotarod, cage activity, and T-maze performance.
• The compound significantly altered brain AchE and Ach levels in AD-induced rats.
• Histopathological examinations supported the neuroprotective effects of baicalein.

Conclusions:

• Baicalein significantly improved the biochemical and histopathological conditions in a rat model of Alzheimer's disease.
• The findings suggest baicalein possesses both protective and therapeutic properties against AD.
• Baicalein represents a promising natural compound for further investigation in Alzheimer's disease treatment.